Munafa Stock Market Course + Intraday & FNO calls 
524816 announcements Natco Pharm announcements and dividends declared BSE
Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816
Natco Pharm 524816 listed on BSE and deals inAnnouncements and dividends declared by Natco Pharm 524816
Patent Row: Delhi HC refuses to ban Natco Pharma's insecticide sale
The Delhi High Court has refused to stop Natco Pharma from selling an insecticide. FMC Corp had alleged patent infringement. The court noted Natco Pharma's strong defense and significant investments. The patent is also nearing expiry. FMC Corp's claims abo
Announcement as on 17 November 2025
Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China
Indian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health ministry for procurement of pharmaceuticals for its hospitals, according to the India-China Economic and Cultural Counc
Announcement as on 11 November 2025
Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea
The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular atrophy. This decision overturns a previous stay, allowing Natco to offer the medication at a significantly lower pric
Announcement as on 09 October 2025
Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator
Natco Pharma Ltd announced that its Kothur unit in Hyderabad received an Establishment Inspection Report (EIR) from the US FDA, classifying the facility as 'Voluntary Action Indicated' (VAI). The US FDA had previously conducted an inspection of the company
Announcement as on 18 September 2025
Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025
Announcements by Natco Pharm first page | Next page | Prev page |
524816 Natco Pharm current price & indicator signals
Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Mon Jun 2026 | 884.35 | 881.80 to 892.75 | -0.5% | 0.19 times |
| 19 Fri Jun 2026 | 888.75 | 877.00 to 909.00 | 0.62% | 0.53 times |
| 18 Thu Jun 2026 | 883.25 | 862.80 to 895.80 | 1.86% | 1.44 times |
| 17 Wed Jun 2026 | 867.10 | 844.05 to 869.00 | 1.83% | 0.87 times |
| 16 Tue Jun 2026 | 851.55 | 841.50 to 858.25 | 0.47% | 0.29 times |
| 15 Mon Jun 2026 | 847.55 | 839.80 to 888.95 | -1.89% | 1.03 times |
| 12 Fri Jun 2026 | 863.85 | 849.75 to 866.00 | 2.53% | 0.7 times |
| 11 Thu Jun 2026 | 842.55 | 839.35 to 874.90 | -1.46% | 1.13 times |
| 10 Wed Jun 2026 | 855.00 | 852.00 to 876.35 | -1.22% | 0.72 times |
| 09 Tue Jun 2026 | 865.55 | 856.10 to 879.70 | -0.35% | 1.03 times |
| 08 Mon Jun 2026 | 868.60 | 864.95 to 908.65 | -2.8% | 2.26 times |
| 05 Fri Jun 2026 | 893.65 | 890.15 to 927.00 | -2.75% | 1.87 times |
Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance
